物质信息
ID:184672
名称和标识
别名
3β,5,14,19-Tetrahydroxy-5β,20(22)-cardenolideK-StrophanthidolStrophanthidol5β,20(22)-Cardenolide-3β,5,14,19-tetrol
IUPAC标准名
4-[5,7,11-trihydroxy-2-(hydroxymethyl)-15-methyltetracyclo[8.7.0.02,7.011,15]heptadecan-14-yl]-2,5-dihydrofuran-2-one
IUPAC传统名
4-[5,7,11-trihydroxy-2-(hydroxymethyl)-15-methyltetracyclo[8.7.0.02,7.011,15]heptadecan-14-yl]-5H-furan-2-one
化合物性质
安全信息
联合国危险货物包装类别(PG)
3
GHS警示性声明
P261-P280-P301+P310-P311
联合国危险货物等级
6.1
GHS危险品标识
急性毒性（口服，皮肤接触，吸入），类别1,2,3
德国WGK号
3
GHS警示词
Danger
个人保护装置
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
RID/ADR
UN 2811 6.1/PG 3
危险公开号
23/24/25
联合国危险货物编号
2811
GHS危险声明
H301-H311-H331
欧盟危险性物质标志
有毒 (T)安全公开号
45
RTECS编号
FH5325000
描述信息
General description
Reduced aglycone of K-strophanthin and cymarin, one of the primary excretion products after use of the glycosides in treatment of congestive heart failure.1
Reduced aglycone of K-strophanthin and cymarin, one of the primary excretion products after use of the glycosides in treatment of congestive heart failure.1
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据